Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience
-
Published:2023-02-06
Issue:4
Volume:12
Page:1275
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Presant Cary A.1, Ashing Kimlin1, Raz Dan1, Yeung Sophia1, Gascon Brenda1, Stewart Alexis1, Macalintal Jonjon1, Sandoval Argelia1, Ehrunmwunsee Loretta1ORCID, Phillips Tanyanika1, Salgia Ravi1ORCID, Merla Amartej1, Subbiah Shanmuga1, El-Hajjouie Michelle1, Staley Jeffrey1, Graves Heather1, Pathak Ranjan1, Dingal Shaira1, Sampath Sagus1, Laksana Beverly1, Joseph Thomas1, Eugenio Tricia1ORCID, Degoma Veronica1, Burns Kathleen1, Phillips Sarah1, Tan Tingting1, Tarkshian Kelly1, Sun Virginia1, Amini Arya1, Davy Khristie1, Cronkhite Janet1, Cianfrocca Mary1, Brown Susan1, Fong Yuman1, Rosen Steven1
Affiliation:
1. City of Hope Medical Center, 1500 East Duarte Rd, Duarte, CA 91010, USA
Abstract
Background: Tobacco control is important for cancer patient health, but delivering effective low-dose CT (LDCT) screening and tobacco cessation is more difficult in underserved and patients from racial and ethnic minority groups. At City of Hope (COH), we have developed strategies to overcome barriers to the delivery of LDCT and tobacco cessation. Methods: We performed a needs assessment. New tobacco control program services were implemented focusing on patients from racial and ethnic minority groups. Innovations included Whole Person Care with motivational counseling, placing clinician and nurse champions at points of care, training module and leadership newsletters, and a patient-centric personalized medicine Personalized Pathways to Success (PPS) program. Results: Emphasis on patients from racial and ethnic minority groups was implemented by training cessation personnel and lung cancer control champions. LDCT increased. Tobacco use assessment increased and abstinence was 27.2%. The PPS pilot program achieved 47% engagement in cessation, with self-reported abstinence at 3 months of 38%, with both results slightly higher in patients from racial and ethnic minority groups than in Caucasian patients. Conclusions: Tobacco cessation barrier-focused innovations can result in increased lung cancer screening and tobacco cessation reach and effectiveness, especially among patients from racial and ethnic minority groups. The PPS program is promising as a personalized medicine patient-centric approach to cessation and lung cancer screening.
|
|